Acura Pharmaceuticals Net Worth 2010-2021 | ACUR

Interactive chart of historical net worth (market cap) for Acura Pharmaceuticals (ACUR) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Acura Pharmaceuticals net worth as of May 09, 2025 is $0B.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.001B $0.000B
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.488B 7.41
Dr Reddy's Laboratories (RDY) India $11.002B 20.99
BridgeBio Pharma (BBIO) United States $6.617B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.766B 14.34
Bausch Health Cos (BHC) Canada $1.702B 1.25
Amphastar Pharmaceuticals (AMPH) United States $1.171B 7.80
Personalis (PSNL) United States $0.456B 0.00
Taysha Gene Therapies (TSHA) United States $0.431B 0.00
Assembly Biosciences (ASMB) United States $0.089B 0.00
Sol-Gel Technologies (SLGL) Israel $0.022B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00